Crawford Receives Recognition for Its Expanded Support of Wound, Ostomy & Continence Nurses Society™

Crawford Receives Recognition for Its Expanded Support of Wound, Ostomy & Continence Nurses Society™

Acknowledgement further validates shared vision of the two organizations.

DOYLESTOWN, Pa., June 22, 2016 – Crawford Healthcare, Inc. (“Crawford” or the “Company”) was recently recognized by the Wound, Ostomy and Continence Nurses Society (WOCN®) with the Silver Supporter Recognition for its support of the Society’s research, advocacy, and programming related to Incontinence Associated Dermatitis (IAD) and other related medical conditions. Crawford’s support of the WOCN Society is largely based upon a common focus in the area of wound, ostomy and continence (WOC)-related ailments. The honor was presented during the WOCN Society and CAET Joint Conference which was held June 4 through 8 in Montreal.

“The WOCN Society is a premiere nursing specialty organization is the world,” says Terry Bromley, Senior Vice President and General Manager of Crawford’s U.S. operations. “Our organizations have shared values and we are proud to stand alongside of them to educate clinicians and improve WOC patient outcomes. Our products support their goals and we are committed to further strengthening this strong partnership moving forward.”

The mission of the WOCN Society is to promote educational, clinical and research opportunities to advance the practice and guide the delivery of expert health care to individuals with wounds, ostomies and incontinence.

Crawford is an international company with global headquarters in the United Kingdom and US operations in Doylestown, Pa.  The company has built a strong reputation for providing innovative products to healthcare professionals and their patients that successfully and cost-effectively treat skin and wound care conditions.

ʺWe are excited about this growing partnership with the team at Crawford,” notes WOCN Society President Carolyn Watts, MSN, RN, CWON. “The Silver Supporter Recognition is well-deserved. They clearly share our goals and support our mission, and we look forward to growing our relationship with them in meaningful ways to continue benefitting patients suffering from WOC-related ailments.”

The largest wound care market in the world is the United States with an estimated $25 billion per year being spent on wound care-related medical costs. These numbers are expected to rise as the number of people in these risk factor categories also continues to rise.  Leading risk factors for developing chronic wounds include diabetes, obesity, and old age.

To learn more about the WOCN Society, visit wocn.org or email info@wocn.org. For more information about Crawford Healthcare, Inc. or its products, please visit us.crawfordhealthcare.com.

About the WOCN® Society
Founded in 1968, the Wound, Ostomy and Continence Nurses Society™ is a professional, international nursing society of over 5,000 health care professionals who are experts in the care of patients with wounds, ostomies and incontinence. The Society supports its members by promoting educational, clinical and research opportunities to advance the practice and guide the delivery of healthcare to individuals with wounds, ostomies and incontinence. Connect with the WOCN Society on Facebook at Wound, Ostomy and Continence Nurses Society (WOCN), on Twitter at @WOCN Society, and on LinkedIn at Wound, Ostomy and Continence Nurses Society™.

About Crawford Healthcare, Inc.
Crawford Healthcare, Inc., is a rapidly growing international company dedicated to developing innovative treatments and effective dermatological, wound care, and diagnostic products for the care and repair of skin. The Company has worked closely with healthcare professionals for more than 15 years from the international head office of its parent company, Crawford Healthcare Holdings Limited (the “Crawford Group”), in Knutsford, Cheshire, U.K. In early 2013, the Crawford Group expanded its operations and opened a United States office in Doylestown, Pa., that focuses on the Company’s portfolio of advanced wound care products. To help lead its U.S. business, the Crawford Group has assembled a skilled management team with long-standing industry backgrounds in the advanced wound care arena. The team offers more than 150 years of collective experience in the field and has deployed a nationwide direct sales team dedicated to wound, skin, and burn care.

Crawford Supports Incontinence-Associated Dermatitis Symposium

Crawford Supports Incontinence-Associated Dermatitis Symposium

DOYLESTOWN, Pa., June 14, 2016 – Crawford Healthcare, Inc. (“Crawford” or the “Company”) recently supported a distinguished group of clinicians for a symposium at the WOCN® Society and CAET Joint Conference. The panel shared their insight and clinical experience in utilizing a novel, touch-free, micro-fine zinc oxide technology to help increase patient comfort, compliance among staff, and treat Incontinence Associated Dermatitis (IAD).

Touchless Care® Zinc Oxide Protectant Spray offers protection and soothing relief for continence conditions and chronic wound care.

Traditionally, IAD has received little attention as a distinct disorder and it is sometimes confused with stage I or II pressure ulcers. Prevention is based on avoiding or minimizing exposure to stool or urine combined with a structured skincare program based on principles of gentle cleansing, moisturization (preferably with an emollient), and application of a skin protectant.  If not properly treated, IAD can lead to pressure ulcers and extended, costly hospital stays.

Crawford’s Touchless Care® Zinc Oxide Protectant Spray is an innovative advanced skin care product for the management and treatment of IAD. The spray-on product utilizes a novel technology designed to advance the standard of skin care in all care settings. The product soothes, protects, and treats irritated skin with 25% Zinc Oxide and 20% Dimethicone without the mess and pain associated with traditional rubbed-in ointments and pastes. The touchless spray application is designed to reduce contact with incontinent patients helping to reduce the chances of cross-contamination between patients and caregivers.

“We are very pleased to support the WOCN conference and this presentation on IAD,” notes Terry Bromley, Senior Vice President and General Manager of Crawford’s U.S. operations. “Our Touchless Care Zinc Oxide Protectant Spray is a natural fit for this discussion on this very challenging condition. Further, working with the WOCN and this highly qualified group of panelists has truly been a rewarding experience for our company.”

The Wound, Ostomy and Continence Nurses Society™ is recognized worldwide for the promotion of safe and effective wound, ostomy and continence (WOC) care. Leading healthcare organizations acknowledge that the Society is the premiere nursing specialty organization to educate clinicians and improve WOC patient outcomes. To learn more, visit wocn.org or email info@wocn.org. For more information about Crawford Healthcare, Inc. or its products, please visit us.crawfordhealthcare.com.

About the WOCN® Society
Founded in 1968, the Wound, Ostomy and Continence Nurses Society™ is a professional, international nursing society of over 5,000 health care professionals who are experts in the care of patients with wounds, ostomies and incontinence. The Society supports its members by promoting educational, clinical and research opportunities to advance the practice and guide the delivery of healthcare to individuals with wounds, ostomies and incontinence. Learn more by visiting wocn.org. Connect with the WOCN Society on Facebook at Wound, Ostomy and Continence Nurses Society (WOCN), on Twitter at @WOCNSociety, and on LinkedIn at Wound, Ostomy and Continence Nurses Society™.

About Crawford Healthcare, Inc.
Crawford Healthcare, Inc., is a rapidly growing international company dedicated to developing innovative treatments and effective dermatological, wound care, and diagnostic products for the care and repair of skin. The Company has worked closely with healthcare professionals for more than 15 years from the international head office of its parent company, Crawford Healthcare Holdings Limited (the “Crawford Group”), in Knutsford, Cheshire, U.K. In early 2013, the Crawford Group expanded its operations and opened a United States office in Doylestown, Pa., that focuses on the Company’s portfolio of advanced wound care products. To help lead its U.S. business, the Crawford Group has assembled a skilled management team with long-standing industry backgrounds in the advanced wound care arena. The team offers more than 150 years of collective experience in the field and has deployed a nationwide direct sales team dedicated to wound, skin, and burn care.